Lifevantage (NASDAQ: LFVN) reported Q4 EPS of $0.14, $0.07 worse than the analyst estimate of $0.21. Revenue for the quarter came in at $48.9 million versus the consensus estimate of $51 million.

GUIDANCE:

Lifevantage sees FY2025 EPS of $0.70-$0.80, versus the consensus of $0.70. Lifevantage sees FY2025 revenue of $200-210 million, versus the consensus of $205.8 million.

For earnings history and earnings-related data on Lifevantage (LFVN) click here.